TY  - GEN
T1  - Antimicrobial Biomaterials: Recent Progress
A2  - Felgueiras, Helena
LA  - eng
PB  - MDPI - Multidisciplinary Digital Publishing Institute
YR  - 2024
UL  - https://ebooks.jgu.edu.in/Record/doab-20.500.12854-143791
AB  - Biomaterials can be used as implantable devices or drug delivery platforms with a significant influence on a patients’ quality of life. Indeed, every year a substantial number of new biomaterials and scaffolding systems are engineered and introduced in the biomedical field with increased potential for biomedical uses. However, their long-term use can be threatened by the adhesion and proliferation of microorganisms, which can interact and form biofilms, or the formation of fibrosis, with cytotoxic responses being very common. Pathogenic microorganisms may cause local infection and consequent implant failure; furthermore, they can hinder the delivery of therapeutic molecules by specialized delivery platforms, turning them ineffective. Many alternatives have been proposed over the years to prevent such events, including the use of antiseptics and antibiotics or the physical modification of the biomaterial surface, with the incorporation of biomolecules of interest. From specialized polymers and functional groups to silver and, more recently, antimicrobial peptides and natural extracts, different functionalization/modification techniques have been employed in this fight against pathogenic agents.
SN  - 9783725816606
SN  - 9783725816590
KW  - soy protein isolate
KW  - quaternization
KW  - antibacterial property
KW  - wound healing
KW  - antimicrobial therapy
KW  - antimicrobial resistance
KW  - drug delivery systems
KW  - antimicrobials delivery
KW  - nanocarriers
KW  - antibacterial nanoformulations
KW  - antifungal nanoformulations
KW  - antiviral nanoformulations
KW  - antiparasitic nanoformulations
KW  - chitosan nanoparticles
KW  - yellow everzol textile dyes
KW  - biocompatibility
KW  - HaCat cells
KW  - antimicrobial activity
KW  - skin pathogens
KW  - cell infection assays
KW  - multidrug resistance
KW  - nanoparticles
KW  - antibiotic combinations
KW  - infectious disease
KW  - chitosan
KW  - fruit quality parameters
KW  - sweet orange essential oil
KW  - phosphoric acid
KW  - preharvest treatments
KW  - Ag@AgCl nanoparticles
KW  - synthesis mechanisms
KW  - Shewanella sp.
KW  - dye reduction
KW  - antibacterial activity
KW  - CO2 laser
KW  - Enterococcus faecalis
KW  - erbium laser
KW  - oral pathogens
KW  - Streptococcus mutans
KW  - Streptococcus sanguinis
KW  - drug resistance
KW  - molecular diagnosis
KW  - anti-tuberculosis therapy
KW  - Real-Time PCR
KW  - isoniazid
KW  - rifampicin
KW  - genomic DNA
KW  - mutation
KW  - vitreous enamel
KW  - antimicrobial coatings
KW  - silver
KW  - fungicidal activity
KW  - antimicrobial
KW  - antimycobacterial
KW  - benzoxaborole
KW  - cytotoxicity
KW  - molecular docking
KW  - multidrug-resistant tuberculosis
KW  - tuberculosis
KW  - 1H-benzo[d]imidazole derivatives
KW  - structure–activity relationship
KW  - X-ray
KW  - ADME
KW  - crossing the blood–brain barrier
KW  - cellobiose dehydrogenase
KW  - immobilization
KW  - antioxidant
KW  - cytotoxic
KW  - external ventricular drain
KW  - biofilm
KW  - bacteria
KW  - silver nanoparticles
KW  - antibiotics impregnated
KW  - biomaterial
KW  - porous silica spheres
KW  - porosity
KW  - surface area
KW  - microbial activity
KW  - enzyme activity
KW  - antibiotic resistance
KW  - click chemistry
KW  - photopolymerization
KW  - AMP-releasing
KW  - self-assembling
KW  - hydrogel
KW  - antimicrobial peptide
KW  - orthodontic brackets
KW  - S-Nitroso-N-Acetylpenicillamine (SNAP)
KW  - orthodontic ligatures
KW  - dental plaque
KW  - antibacterial chains
KW  - elastomeric chainswhite spot lesions
KW  - nitric oxide
KW  - SNAP
KW  - n/a
KW  - thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
ER  -